Last reviewed · How we verify
Dialysis Solutions
At a glance
| Generic name | Dialysis Solutions |
|---|---|
| Sponsor | A.O.U. Città della Salute e della Scienza |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Expanded Hemodialysis Versus High-Volume Online Hemodiafiltration for Uremic Toxin Removal (NA)
- Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial (PHASE3)
- Efficacy and Safety of XyloCore Peritoneal Dialysis Solution. (PHASE3)
- Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysis (PHASE1)
- Impact of CRRT on Serum Carnitine and Micronutrient Levels
- Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU) (PHASE2)
- Can Changes in Dialysate Sodium Concentration Improve Blood Pressure and Endothelial Function in Chronic HD Patients? (NA)
- Optimisation of Solute Removal and Water Usage in Paediatric Haemodialysis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dialysis Solutions CI brief — competitive landscape report
- Dialysis Solutions updates RSS · CI watch RSS
- A.O.U. Città della Salute e della Scienza portfolio CI